A single peer-reviewed laboratory study tested a film containing gold nanoparticles and antibodies as a protein sensor. Increasing GDF-15 concentrations lowered electrical resistance and raised the readout frequency. Antibody-free films lacked the same notable response. Measurements with prepared solutions suggest a compact sensing approach, while patient diagnostic accuracy remains untested and manually deposited films introduce variation between devices.
Yi-Hsiu Kao and colleagues tested a protein biosensor in a single peer-reviewed laboratory study. A thin film between two electrodes contains gold nanoparticles, antibodies selected for the target and a polyvinyl-alcohol-based polymer matrix. Five-nanometre gold particles form a conducting network sensitive to small changes. The sensing area on glass measures 3.5 by 3.5 millimetres.[1]
Prepared solutions of GDF-15, the target protein biomarker, were pipetted onto the film. Tested concentrations ran from 23.4 to 1500 picograms per millilitre. Effective resistance declined as concentration rose, while the oscillator readout ran at a higher frequency. Each impedance point averaged five separate biosensors. Electrical responses were measured five times at each concentration, providing repeated measurements of the laboratory response.[1]
Antibody-free films did not show the same notable concentration dependence; their control measurements were repeated three times. Experiments also compared pH 7 and pH 8, with a marginally higher baseline frequency at pH 8. The reported response time was approximately thirty seconds.[1]
Manual drop-casting can vary film thickness and morphology, leading the authors to propose standardized deposition for manufacture. Impedance measurements do not uniquely identify the microscopic transport mechanism. The experiments used prepared protein solutions and did not evaluate diagnostic sensitivity or specificity in patients. The electrical sensing response remains a laboratory result rather than a demonstrated clinical classification.[1]
